Rapid Market Growth Gateway Genomics has demonstrated consistent growth, being recognized multiple years in the Inc 5000 list and expanding its consumer genetic testing offerings, indicating increasing market demand for direct-to-consumer prenatal and pediatric genetic tests.

Strategic Acquisition The company was acquired by Myriad Genetics for 67.5 million dollars, reflecting its valuable market position and providing a potential entry point for partners interested in collaborating with a proven leader in genetic testing.

Product Expansion Gateway Genomics launched new direct-to-consumer products like SneakPeek Snap and SneakPeek Early Traits, offering multiple entry points for sales efforts targeting expectant parents and families seeking genetic insights about their children.

Brand Partner Initiatives The implementation of the SneakPeek Brand Affiliates program provides opportunities to engage with partners and healthcare providers, enabling expansion of sales channels through affiliate networks and promotional collaborations.

Focused Niche Market Operating in the specialized biotechnology research industry with a focus on prenatal and pediatric testing, Gateway Genomics offers targeted solutions that can be marketed to healthcare professionals, clinics, and direct consumers interested in genetic health insights for families.